drugset / Trial / NCT00232063
Long-term Study of Ciclosporin for Atopic Dermatitis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
In patients with severe adult atopic dermatitis, the safety and efficacy of OL27-400MEPC will be assessed by repeating oral administration at a dose of 3 mg/kg/day (2-5 mg/kg/day) in 2 divided doses daily for 8-12 weeks and recovery until 52 weeks after starting treatment
Timeline
- Start
- 2004-05
- Primary completion
- 2005-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 3 mg/kg | Oral |